KMT2A and acute lymphoblastic leukemia: In a recent survey of pinometostat treatment a total of 51 adult patients were engaged, 33 of which were AML patients with MLL-r and 4 ALL patients with MLL-r; the total number of patients with MLL-rearrangement represented 72.5% of the total cohort.